학술논문
Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study
Document Type
Article
Author
Ghalwash, Mohamed; Anand, Vibha; Lou, Olivia; Martin, Frank; Rewers, Marian; Ziegler, Anette-G; Toppari, Jorma; Hagopian, William A; Veijola, Riitta; Achenbach, Peter; Bonifacio, Ezio; Crouch, Claire; Dunne, Jessica; Elding Larsson, Helena; Frohnert, Brigitte I; Hu, Jianying; Hyöty, Heikki; Ilonen, Jorma; Jönsson, Josefin; Killian, Michael; Knip, Mikael; Koski, Eileen; Lernmark, Åke; Li, Ying; Li, Zhiguo; Liu, Bin; Lundgren, Markus; Malhotra, Ashwani; Maziarz, Marlena; Meyer, Jocelyn; Moore, Shelley; Ng, Kenney; Norris, Jill; Roy, Shreya; Spiliopoulos, Lampros; Steck, Andrea; Stavropoulos, Harry; Waugh, Kathleen; Winkler, Christiane; Yu, Liping
Source
The Lancet Child & Adolescent Health; April 2023, Vol. 7 Issue: 4 p261-268, 8p
Subject
Language
ISSN
23524642; 23524650
Abstract
Screening for islet autoantibodies in children and adolescents identifies individuals who will later develop type 1 diabetes, allowing patient and family education to prevent diabetic ketoacidosis at onset and to enable consideration of preventive therapies. We aimed to assess whether islet autoantibody screening is effective for predicting type 1 diabetes in adolescents aged 10−18 years with an increased risk of developing type 1 diabetes.